| 发明名称 |
β-D-2'-DEOXY-2'α-FLUORO-2'-β-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT |
| 摘要 |
A compound of the structure (A), or a pharmaceutically acceptable salt or composition thereof for the treatment of a host infected with or exposed to an HCV virus or other disorders more fully described herein. |
| 申请公布号 |
WO2016144918(A1) |
申请公布日期 |
2016.09.15 |
| 申请号 |
WO2016US21276 |
申请日期 |
2016.03.07 |
| 申请人 |
ATEA PHARMACEUTICALS, INC. |
发明人 |
SOMMADOSSI, Jean-Pierre;MOUSSA, Adel |
| 分类号 |
A61K31/7076;C07H19/16 |
主分类号 |
A61K31/7076 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
